OBJECTIVE: To address the maternal and neonatal risks of both depression and
antidepressant exposure and develop algorithms for periconceptional and antenatal …

PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH OBSESSIVE-COMPULSIVE
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …

Since the development of pharmacoconvulsive therapy in 1934 and of electroconvulsive
therapy (ECT) in 1938, ECT has proven far more valuable than just the intervention of last …

The selective serotonin reuptake inhibitors (SSRIs) have emerged as a major therapeutic
advance in psychopharmacology. As a result, the discovery of these agents marks a …

Importance Untreated depression during pregnancy has been associated with increased
morbidity and mortality for both mother and child and, as such, optimal treatment strategies …

Since 1975, Robert Julien's A Primer of Drug Action has been the definitive guide to the
effects of psychoactive drugs on the brain and on behavior. Now fully updated, this popular …

Maternal perinatal mental health has enormous consequences for the well-being of the
mother, her baby, and the family. Although it is well documented that perinatal depression is …

Context Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants
and maternal depression both alter neonatal health, and distinguishing the effects of each …

Background The risk of birth defects after antenatal exposure to selective serotonin-reuptake
inhibitors (SSRIs) remains controversial. Methods We assessed associations between first …

Objective: Selective serotonin reuptake inhibitor (SSRI) use during pregnancy incurs a low
absolute risk for major malformations; however, other adverse outcomes have been …